Prognostic value of immunophenotyping in multiple myeloma: a study by the PETHEMA/GEM cooperative study groups on patients uniformly treated with high-dose therapy.
第一作者:
Gema,Mateo
第一单位:
Hospital Universitario de Salamanca, Salamanca, Spain.
作者:
医学主题词
成年人(Adult);老年人(Aged);抗原, CD(Antigens, CD);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);女(雌)性(Female);流式细胞术(Flow Cytometry);人类(Humans);免疫表型分型(Immunophenotyping);原位杂交, 荧光(In Situ Hybridization, Fluorescence);男(雄)性(Male);中年人(Middle Aged);多发性骨髓瘤(Multiple Myeloma);预后(Prognosis);比例危险度模型(Proportional Hazards Models);前瞻性研究(Prospective Studies);存活率(Survival Rate)
DOI
10.1200/JCO.2007.15.4120
PMID
18443352
发布时间
2015-11-19
- 浏览146
Journal of clinical oncology
2737-44页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



